Small cell lung cancer transformation and tumor heterogeneity after sequential targeted therapy and immunotherapy in EGFR-mutant non-small cell lung cancer: A case report

BACKGROUND: Histological transformation from non-small cell lung cancer (NSCLC) to small cell lung cancer (SCLC) is one of mechanisms of the acquired resistance to epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKI). However, SCLC transformation and tumor heterogeneity have neve...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Meng-Hang, Yu, Jia, Cai, Chen-Lei, Li, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9768476/
https://www.ncbi.nlm.nih.gov/pubmed/36568150
http://dx.doi.org/10.3389/fonc.2022.1029282

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9768476/
https://www.ncbi.nlm.nih.gov/pubmed/36568150
http://dx.doi.org/10.3389/fonc.2022.1029282

Ejemplares similares